ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin β3

Journal of Cellular Physiology

Volumn 178, Issue 2, 1999, Pages 121-132

  Oda, Nobuyuki ^a   Abe, Mayumi ^a   Sato, Yasufumi ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANTISENSE OLIGODEOXYNUCLEOTIDE; COLLAGENASE; FOCAL ADHESION KINASE; GELATINASE B; INTEGRIN; MATRIX METALLOPROTEINASE; STROMELYSIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS 1; UNCLASSIFIED DRUG; VINCULIN; VITRONECTIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL GROWTH; CELL INVASION; CELL LINE; CELL PROLIFERATION; ENDOTHELIUM CELL; GENE EXPRESSION; GROWTH RATE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION;

ACTINS; ANIMALS; ANTIGENS, CD; BASE SEQUENCE; CELL ADHESION; CELL ADHESION MOLECULES; CELL DIVISION; CELL LINE; COLLAGENASES; DNA PRIMERS; ENDOTHELIUM, VASCULAR; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION; INTEGRIN BETA3; INTEGRINS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; PLATELET MEMBRANE GLYCOPROTEINS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RECEPTORS, VITRONECTIN; TRANSCRIPTION FACTORS; VINCULIN;

EID: 0032921704     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199902)178:2<121::AID-JCP1>3.0.CO;2-F     Document Type: Article

References (49)

1. Blaschuk KL, Guérin C, Holland PC. 1997. Myoblast αvβ3 integrin levels are controlled by transcriptional regulation of expression oh the β3 subunit and down-regulation of β3 subunit expression is required for skeletal muscle cell differentiation. Dev Biol 184:266-277.
2. Benz CC, O'Hagan RC, Richter B, Scott GK, Chang C, Xiong X, Chew K, Ljung B, Edgerton S, Thor A, Hassell JA. 1997. HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer. Oncogene 15:1513-1525.
3. Block KL, Shou Y, Poncz M. 1996. An Ets/Sp1 interaction in the 5' flanking region of the megakaryocyte-specific alpha IIb gene appears to stabilize Sp1 binding and is essential for expression of this TATA-less gene. Blood 88:2071-2080.
4. Bolon I, Gouyer V, Devouassoux M, Vandenbunder B, Wernert N, Moro D, Brambilla C, Brambilla E. 1995. Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. Am J Pathol 147:1298-1310.
5. Bolon I, Brambilla E, Vandenbunder B, Robert C, Lantuejoul S. Brambilla C. 1996. Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions. Lab Invest 75:1-13.
6. Boudreau N, Andrews C, Srebrow A, Ravanpay A, Cheresh DA. 1997. Induction of the angiogenic phenotype by Hox-D3. J Cell Biol 139: 257-264.
7. Bradford AP, Courad KE, Wasylyk C, Wasylyk B, Gutierrez-Hartmann A. 1995. Functional interaction of c-Ets-1 and GHF-1/Pit-1 mediates ras activation of pituitary-specific gene expression: mapping of essential c-Ets-1 domain. Mol Cell Biol 15:2849-2857.
8. Brooks PC, Clark RAF, Cheresh DA. 1994a. Requirement of vascular integrin αvβ3 for angiogenesis. Science 264:569-571.
9. Brooks PC, Montgomery AMP, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA. 1994b. Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157-1164.
10. Brooks PC, Strömblad S, Sanders LC, Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA. 1996. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 85:683-693.
11. Cao X, Ross FP, Zhang L, MacDonald PN, Chappel J, Teitelbaum SL. 1993. Cloning of the promoter for the avian integrin β3 subunit gene and its regulation by 1,25-dihydroxyvitamine D3. J Biol Chem 268:27371-27380.
12. Chen Z, Fisher RJ, Li B, Tanaka T, Kung H, Lautenberger JA, Rhim JS. 1997. Elevated expression of ETS-1 gene in a metastatic, tumorigenic human prostate epithelial cell line transformed by the v-Ki-ras oncogene. Int J Oncol 11:1179-1184.
13. Clark EA, Brugge JS. 1995. Integrins and signal transduction pathways: the road taken. Science 268:233-239.
14. Doubeikovski A, Uzan G, Doubeikovski Z, Prandini MH, Porteu F, Gisselbrecht S, Dusanter-Fourt I. 1997. Thrombopoietin-induced expression of the glycoprotein IIb gene involves the transcription factor PU.1/Spi-1 in UT7-Mp1 cells. J Biol Chem 272:24300-24307.
15. Duhamel-Clérin E, Orvain C, Lanza F, Cazenave J, Klein-Soyer C. 1997. Thrombin receptor-mediated increase to two matrix metallo-proteinase, MMP-1 and MMP-3, in human endothelial cells. Arterioscler. Thromb Vasc Biol 17:1931-1938.
16. Folkman J, Shing Y. 1992. Angiogenesis. J Biol Chem 267:10931-10934.
17. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA. 1995. Definition of two angiogenic pathways by distinct av integrins. Science 270:1500-1502.
18. Gilles C, Polette M, Birembaut P, Brunner N, Thompson EW. 1997. Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines. Clin Exp Metastasis 15:519-526.
19. Gum R, Lengyel E, Juarez J, Chen JH, Sato H, Seiki M, Boyd D. 1996. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J Biol Chem 271:10672-10680.
20. Gumbiner BM. 1996. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84:345-357.
21. Gutman A, Wasylyk B. 1990. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J 9:2241-2246.
22. Herron GS, Werb Z, Dwyer K, Banda MJ. 1986. Secretion of metalloproteinases by stimulated capillary endothelial cells. J Biol Chem 261:2810-2813.
23. Hida K, Shindoh M, Yasuda M, Hanzawa M, Funaoka T, Kohgo K, Amemiya A, Totsuka Y, Yoshida K, Fujinaga K. 1997. Antisense E1AF transfection restrains oral cancer invasion by reducing matrix metalloproteinase activities. Am J Pathol 150:2125-2132.
24. Higashino F, Yoshida K, Noumi T, Seiki M, Fujinaga K. 1995. Etsrelated protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene 10:1461-1463.
25. Howard PW, Maurer RA. 1995. A composite Ets/Pit-1 binding site in the prolactin gene can mediate transcriptional responses to multiple signal transduction pathways. J Biol Chem 270:20930-20936.
26. Iwasaka C, Tanaka K, Abe M, Sato Y. 1996. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cell Physiol 169:522-531.
27. Jorcyk CL, Garrett LJ, Maroulakou IG, Watson DK, Green JE. 1997. Multiple regulatory regions control the expression of Ets-1 in the developing mouse: vascular expression conferred by intron I. Cell Mol Biol 43:211-225.
28. Kola I, Brookes S, Green AR, Garber R, Tymms M, Papas TS, Seth A. 1993. The Ets-1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc Natl Acad Sci USA 90:7588-7592.
29. 5-directed cell motility but not adhesion on vitronectin. J Cell Biol 127:859-866.
30. Lauffenburger DA, Horwitz AF. 1996. Cell migration: a physically integrated molecular process. Cell 84:359-369.
31. 5-dependent cytoskeletal association and focal adhesion kinase phosphorylation. J Cell Biol 134:1323-1332.
32. Nakayama T, Ito M, Ohtsuru A, Naito S, Nakashima M, Fagin JA, Yamashita S, Sekine I. 1996. Expression of the Ets-1 proto-oncogene in human gastric carcinoma. Correlation with tumor invasion. Am J Pathol 149:1931-1939.
33. Nerlov C, Rorth P, Blasi F, Johnsen M. 1991. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene 6:1583-1592.
34. Nerlov C, De Cesare D, Pergola F, Caracciolo A, Blasi F, Johnsen M, Verde P. 1992. A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells. EMBO J 11:4573-4582
35. Niwa H, Yamamura K, Miyazaki J. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108: 193-200.
36. Pardonaudo L, Dieterlen-Lièvre F. 1993. Expression of C-ETS-1 in early chick embryo mesoderm: relationship to the Hemangioblastic Lineage. Cell Adhesion Commun 1:151-160.
37. Risau W. 1997. Mechanisms of angiogenesis. Nature 386:671-674.
38. Seth A, Papas TS. 1990. The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated. Oncogene 5:1761-1767.
39. Shindoh M, Higashino F, Kaya M, Yasuda M, Funaoka K, Hanzawa M, Hida K, Kohgo T, Amemiya A, Yoshida K, Fujinaga K. 1996. Correlated expression of Matrix metalloproteinases and ets family transcription factor E1A-Fin invasive oral squamous-cell-carcinoma-derived cell lines. Am J Pathol 148:693-700.
40. Tanaka K, Oda N, Iwasaka C, Abe M, Sato Y. 1998. Induction of Ets-1 in endothelial cells during reendothelialization after denuding in-jury. J Cell Physiol 176:235-244.
41. Vacca A, Moretti S, Ribatti D, Pellegrino A, Pimpinelli N, Bianchi B, Bonifazi E, Ria R, Serio G, Dammacco F. 1997. Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinase 2 and 9. Eur J Cancer 33:1685-1692.
42. Vandenbunder B, Pardanaud L, Jaffredo T, Mirabel MA, Stehelin D. 1989. Complementary patterns of expression of c-ets-1, c-myb and c-myc in the blood-forming system of the chick embryo. Development 106:265-274.
43. Villa-Garcia M, Li L, Riely G, Bray PF. 1994. Isolation and characterization of a TATA-less promoter for the human β3 integrin gene. Blood 83:668-676.
44. Wasylyk C, Gutman A, Nicholson R, Wasylyk B. 1991. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J 10:1127-1134.
45. Wasylyk B, Harn SL, Giovane A. 1993. The Ets family of transcription factors. Eur J Biochem 15:7-18.
46. Werb Z. 1997. ECM and cell surface proteolysis: regulating cellular ecology. Cell 91:439-442.
47. Wernert N, Raes M, Lassalle P, Dehouck M, Gosselin B, Vandenbunder B, Stehelin D. 1992. C-ets-1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am J Pathol 140:119-127.
48. Yanai N, Satoh T, Obinata M. 1991. Endothelial cells create a hematopoietic inductive microenvironment preferential to erythropoiesis in the mouse spleen. Cell Struct Funct 16:87-93.
49. Zucker S, Conner C, Dimassmo BI, Ende H, Drews M, Seiki M, Bahou WF. 1995. Thrombin induces the activation of progelatinase A in vascular endothelial cells. Physiologic regulation of Angiogenesis. J Biol Chem 270:23730-23738.